MAR 30, 2017 10:45 AM PDT

Newly Identified Risk Loci for Gliomas

WRITTEN BY: Xuan Pham

A new research into the causes of deadly brain cancer implicates 13 new genetic regions. This doubles the number of known genetic mutations that seem to increase the risk for glioma – one of the most common forms of brain cancer.

The study was an international collaboration with researchers from Europe, the United Kingdom, and the United States. The meta-analysis included data on nearly 12,500 patients with gliomas, and over 18,000 healthy individuals.

The large sample size allowed the researchers to more precisely identify genetic susceptibility regions with a genetic tool known as a genome-wide association study (GWAS). With this analysis, they found 5 new genetic regions that increase the risk for a deadly form of glioma known as glioblastoma multiforme (GBM). They also found 8 new regions that are associated with increased risk of non-GBM tumors – a less lethal glioma type.

The genetic regions implicated in this study are linked to cell division, cell cycle regulation, neurogenesis, and regulation of some key proteins.

"The changes in the way we think about glioma could be quite fundamental," said Richard Houston, the study’s co-senior author. "So for example, what we thought of as two related subtypes of the disease turn out to have quite different genetic causes which may require different approaches to treatment."

Of note, gliomas make up about 27 percent of all brain cancers, which result in 13,000 deaths every year. In particular, the GBM form of glioma is particularly aggressive and notorious for the dismally grim 5-year survival rate of less than 10 percent.

"It has been exciting to have been involved in such a gigantic study including cases of brain cancer from all over the world. We have uncovered a treasure trove of new information about the genetic causes of glioma brain cancers,” said Houlston. “Understanding the genetics of glioma in such detail allows us to start thinking about ways of identifying people at high inherited risk, and will open up a search for new treatments that exploit our new knowledge of the biology of the disease."

Additional sources: MNT

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JUL 17, 2018
Cancer
JUL 17, 2018
New Small Cell Lung Cancer Subtype Identified
A new subtype of small cell lung cancer is reported to account for potentially 20% of small cell lung cancers diagnosed; it has unique molecular biomarkers and regulatory mechanisms....
AUG 07, 2018
Cancer
AUG 07, 2018
Is There a Best Time of Day to Administer Chemo?
A common hematologic cancer chemotherapy agent is looked at for its efficacy on solid tumors and specifically evaluates if delivery time during the day affects is anti-tumor activity....
SEP 11, 2018
Cannabis Sciences
SEP 11, 2018
New Evidence Shows Marijuana Smoke is Not the Same as Cigarette Smoke, at Least, in Terms of Lung Disease.
A recent report published in the journal Breathe by scientists in the UK suggests that chronic marijuana smoking may not cause the same deleterious effects...
OCT 06, 2018
Genetics & Genomics
OCT 06, 2018
Genetic Mutation Linked to Increased Pancreatic Cancer Risk in Women
In a first, researchers have found a genetic mutation that has a sex-specific effect on pancreatic cancer risk....
OCT 29, 2018
Neuroscience
OCT 29, 2018
Gut: a second brain and novel therapeutic target
Undersatnding the role of gut microbiome in disease pathologies and targetting them for potential treatment strategies....
NOV 14, 2018
Immunology
NOV 14, 2018
Rapid Tumor Targeting
Researchers at the University of California Irvine have developed a technology that will rapidly identify and target T cell receptors for tumor specific antigens...
Loading Comments...